Purpose On clinical examination, it can be challenging to differentiate retinoschisis with outer retinal hole from schisis-detachment. This study examined the role of outer retinal hole spectral ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

The retina is a light-sensitive tissue lining the back of the eye that converts light into electrical signals, which are then sent to the brain to create vision. Retinal detachment happens when the ...

Introduction Voretigene neparvovec-rzyl (Luxturna) was approved by the Australian Therapeutic Goods Administration on 4 August 2020 for the treatment of biallelic mutations in the RPE65 gene, a rare ...

Ocular Therapeutix is making sure its corporate vision is 20/20 as it looks forward to phase 3 data on its eye disease drug candidate Axpaxli.

Ocular Therapeutix, Inc. is a fully-integrated biopharmaceutical company committed to redefining the retina experience. AXPAXLI™ (also known as OTX-TKI), Ocular’s investigational product candidate for ...

Ocular Therapeutix launched new branding and website, focusing on innovative treatments for retinal diseases, particularly wet AMD.

The new branding showcases the Company's innovative vision for the future and mission to redefine the retina experienceBEDFORD, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc ...

Serous retinal detachment can be caused by a wide range of conditions, including systemic lupus erythematosus. Although this association has been well-described in patients with an established ...

The ultrasonic properties of ocular tissues including sclera, cornea, ciliary body and iris have been quantitatively evaluated over the frequency range from 50 MHz to 100 MHz at 37/spl deg/C.